Acknowledgements
The President’s Cancer Panel is grateful to all participants who invested their time in the series of workshops on cancer screening and to the members of the Working Group on Cancer Screening During the COVID-19 Era, who guided workshop planning (see Series Information). The Panel is especially thankful to the following Working Group members who chaired subcommittees for each of the cancer types covered in the series.
Al B. Benson, III, MD, FACP, FASCO, Northwestern University Feinberg School of Medicine
V. Paul Doria-Rose, DVM, PhD, National Cancer Institute
Kevin S. Hughes, MD, FACS, Medical University of South Carolina
Worta McCaskill-Stevens, MD, National Cancer Institute
Rebecca Perkins, MD, Boston University School of Medicine/Boston Medical Center
Mitchell D. Schnall, MD, PhD, University of Pennsylvania Perelman School of Medicine
Richard C. Wender, MD, University of Pennsylvania Perelman School of Medicine
Nicolas Wentzensen, MD, PhD, MS, National Cancer Institute
The Panel appreciates the thoughtful comments provided by the following individuals who shared their expertise and/or provided feedback on early drafts of the report. Acknowledgment of the important role of these reviewers should not be interpreted as endorsement of the Panel’s positions or recommendations.
Elise S. Anthony, JD, Office of the National Coordinator for Health Information Technology
Ryan Argentieri, MBA, Office of the National Coordinator for Health Information Technology
Tracy Battaglia, MD, MPH, Boston University Schools of Medicine and Public Health
Sarah Coles, MD, Banner Health
Anjelica Davis, MPPA, Fight Colorectal Cancer
Chyke A. Doubeni, MBBS, MPH, Mayo Clinic
Venus Ginés, MA, P/CHWI, Día de la Mujer Latina
Heather Hampel, MS, LGC, The Ohio State University College of Medicine
Kathy J. Helzlsouer, MD, MHS, National Cancer Institute
Paul Jacobsen, PhD, National Cancer Institute
Nilesh Kalyanaraman, MD, Anne Arundel County Department of Health
Warren A. Kibbe, PhD, Duke University
Bron Kisler, CDISC
Alex H. Krist, MD, MPH, Virginia Commonwealth University
Edwin Lomotan, MD, Agency for Healthcare Research and Quality
Thomas A. Mason, MD, Office of the National Coordinator for Health Information Technology
Folasade P. May, MD, PhD, MPhil, UCLA Health
Maria Michaels, MBA, PMP, Centers for Disease Control and Prevention
Elisabeth Myers, MBA, Office of the National Coordinator for Health Information Technology
Lori A. Orlando, MD, MHS, Duke University School of Medicine
Steven Posnack, MS, MHS, Office of the National Coordinator for Health Information Technology
Mona Saraiya, MD, MPH, Centers for Disease Control and Prevention
Avinash Shanbhag, MS, Office of the National Coordinator for Health Information Technology
Mario Teran, MD, Agency for Healthcare Research and Quality
The Panel also acknowledges the efforts and contributions of Panel staff and support staff:
Janet Braun, CMP
Daniel Eckstein, MA
Samantha L. Finstad, PhD
Rebecca Hardesty, PhD
Randi LW Hays
William Huggins
Maureen Johnson, PhD
Brian Johnson, PhD
Erin Milliken, PhD
Benjamin Neal
Katherine Nicol, MS
Jennifer Owers
Catherine A. Schweppe, PhD
Scott Wheeler, MS
Rachel Wojnilower
Dana Young, JD